Additional file 1: of Therapy of nodal Follicular Lymphoma (WHO grade 1/2) in clinical stage I/II using response adapted Involved Site Radiotherapy in combination with Obinutuzumab (Gazyvaro) - GAZAI Trial (GAZyvaro and response adapted Involved-site Radiotherapy): a study protocol for a single-arm, non-randomized, open, national, multi-center phase II trial Laila KĂśnig Martin Dreyling Jan DĂźrig Marianne Engelhard Karin Hohloch Andreas Viardot Mathias Witzens-Harig Meinhard Kieser Wolfram Klapper Christiane Pott Klaus Herfarth 10.6084/m9.figshare.9756071.v1 https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_of_Therapy_of_nodal_Follicular_Lymphoma_WHO_grade_1_2_in_clinical_stage_I_II_using_response_adapted_Involved_Site_Radiotherapy_in_combination_with_Obinutuzumab_Gazyvaro_-_GAZAI_Trial_GAZyvaro_and_response_adapted_Involved-/9756071 SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) 2013 Checklist: Recommended items to address in a clinical trial protocol and related documents. (DOC 236 kb) 2019-08-31 08:23:17 Follicular lymphoma Low-dose radiotherapy Obinutuzumab Anti-CD20 antibody Involved site radiotherapy PET/CT